Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Saudi Med ; 41(6): 313-317, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34873935

RESUMO

BACKGROUND: Intravascular intrauterine transfusion (IUT) is considered a safe procedure, but complications still occur, including fatalities. OBJECTIVE: Review the outcomes of Rh alloimmunization, including indications and possible complications. DESIGN: Retrospective cohort (medical record review). SETTING: Tertiary care center. PATIENTS AND METHODS: We retrieved the records for all mothers who had an IUT for Rh alloimmunization between January 2009 and August 2019. We collected data on complications, post-transfusion hemoglobin and antibody combinations. MAIN OUTCOME MEASURE: Complications of IUT. SAMPLE SIZE: 119 mothers with 154 fetuses (154 different pregnancies). RESULTS: The 154 fetuses had 560 intrauterine transfusions. The median pre-IUT hemoglobin was a median of 8.0 g/dL while the median post-IUT hemoglobin 16 g/dL. Immediate procedure-related complications included fetal bradycardia in 2.7%, significant bleeding from the cord puncture site (for more than 2 minutes in 0.9%), and contractions in 0.9%. Eight (5.2%) were delivered by cesarean delivery due to IUT-specific complications such as post-procedure fetal bradycardia. Intrauterine fetal death complicated 8.4% of the pregnancies (13 fetuses). Phototherapy was required in 76 (49.4%), postnatal blood transfusions in 17 (11%), and exchange transfusion in 11 (7.1%). Neonatal death occurred 8 (5.2%). Data were insufficient to assess associations of complications with antibody combinations. CONCLUSIONS: Intrauterine transfusion is an effective treatment with high survival rates (around 90% for cases of Rh alloimmunization). LIMITATIONS: Case series. CONFLICT OF INTEREST: None.


Assuntos
Transfusão de Sangue Intrauterina , Morte Fetal , Transfusão de Sangue , Transfusão de Sangue Intrauterina/efeitos adversos , Estudos de Coortes , Feminino , Humanos , Recém-Nascido , Gravidez , Estudos Retrospectivos
2.
J Obstet Gynaecol Res ; 40(1): 293-6, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24102864

RESUMO

Maternal floor infarction is a relatively rare condition characterized clinically by severe early onset fetal growth restriction with features of uteroplacental insufficiency. It has a very high recurrence rate and carries a significant risk or fetal demise. Pathological characteristics include massive and diffuse fibrin deposition along the decidua basalis and the perivillous space of the basal plate. We present a case of recurrent maternal floor infarction and propose diagnostic clues as well as potential therapeutic options.


Assuntos
Retardo do Crescimento Fetal/etiologia , Infarto/fisiopatologia , Placenta/irrigação sanguínea , Circulação Placentária , Insuficiência Placentária/fisiopatologia , Adulto , Feminino , Morte Fetal/etiologia , Retardo do Crescimento Fetal/prevenção & controle , Fibrina/metabolismo , Humanos , Infarto/patologia , Infarto/prevenção & controle , Infarto/terapia , Placenta/metabolismo , Placenta/patologia , Insuficiência Placentária/patologia , Insuficiência Placentária/prevenção & controle , Insuficiência Placentária/terapia , Gravidez , Prevenção Secundária , Índice de Gravidade de Doença , Regulação para Cima , Doenças Uterinas/patologia , Doenças Uterinas/fisiopatologia , Doenças Uterinas/prevenção & controle , Doenças Uterinas/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...